{"news_desk": "Foreign", "print_page": "4", "section_name": "Health", "subsection_name": null, "document_type": "article", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2015/01/10/world/VACCINE/VACCINE-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2015/01/10/world/VACCINE/VACCINE-thumbWide.jpg"}, {"height": 401, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "401", "xlarge": "images/2015/01/10/world/VACCINE/VACCINE-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2015/01/10/world/VACCINE/VACCINE-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/01/10/world/VACCINE/VACCINE-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2015/01/10/world/VACCINE/VACCINE-thumbStandard.jpg"}], "abstract": "World Health Organization adviser Dr Helen Rees says developing and testing Ebola vaccines and their effectiveness may become more difficult as outbreak comes under greater control; two vaccines have been determined to be safe enough in tests taking place in countries outside outbreak zones, but dosages have not been calibrated and it is not known if they are effective in Africa's most heavily impacted countries.", "type_of_material": "News", "word_count": "947", "lead_paragraph": "Clinical trials in Africa are being pushed by a sense of urgency as fewer new cases occur, making it more difficult to determine how effective the drugs are.", "pub_date": "2015-01-10T00:00:00Z", "_id": "54b02f8e38f0d8367c841399", "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "source": "The New York Times", "snippet": "Clinical trials in Africa are being pushed by a sense of urgency as fewer new cases occur, making it more difficult to determine how effective the drugs are.", "web_url": "http://www.nytimes.com/2015/01/10/health/ebbing-of-ebola-complicates-testing-of-vaccines.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "Y", "value": "Ebola Virus", "name": "subject"}, {"rank": "11", "is_major": "N", "value": "Merck & Company Inc", "name": "organizations"}, {"rank": "12", "is_major": "N", "value": "National Institutes of Health", "name": "organizations"}, {"rank": "13", "is_major": "N", "value": "Public Health Agency of Canada", "name": "organizations"}, {"rank": "14", "is_major": "N", "value": "Guinea", "name": "glocations"}, {"rank": "15", "is_major": "N", "value": "Liberia", "name": "glocations"}, {"rank": "16", "is_major": "N", "value": "Sierra Leone", "name": "glocations"}, {"rank": "17", "is_major": "N", "value": "Switzerland", "name": "glocations"}, {"rank": "18", "is_major": "N", "value": "Kieny, Marie-Paule", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "World Health Organization", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Africa", "name": "glocations"}, {"rank": "4", "is_major": "Y", "value": "Vaccination and Immunization", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Rees, Helen V (1953- )", "name": "persons"}, {"rank": "6", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Epidemics", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "10", "is_major": "N", "value": "Johnson & Johnson", "name": "organizations"}], "headline": {"main": "In Africa, a Decline in New Ebola Cases Complicates Vaccine Development", "print_headline": "In Africa, a Decline in New Ebola Cases Complicates Vaccine Development"}}